Embedding Transporter Clearance in the Well-Stirred Liver

From Transporter Kinetics to Organ Clearance

Hepatic uptake and efflux determine how much drug reaches hepatocytes and how much returns to blood, while metabolism and biliary excretion determine how much is irreversibly removed. These processes first produce a transporter-dependent net intrinsic clearance. To predict clearance from blood across the whole liver, that net quantity must be combined with hepatic blood flow and the unbound fraction in blood.

The well-stirred liver model makes this connection with a compact mass balance. Its key implication is that a large intrinsic clearance does not produce arbitrarily large organ clearance: as intrinsic clearance increases, hepatic clearance approaches the limit set by blood flow. The equations below assume linear kinetics at the concentrations considered.

Definition: \(CL_{\mathrm{int,net}}\) is the effective intrinsic clearance for irreversible hepatic removal, referred to the unbound drug concentration in blood. It summarizes the net result of transporter-dependent access to hepatocytes, return of drug to blood, and irreversible intracellular loss. \(Q_H\) is hepatic blood flow, \(f_{u,b}\) is the fraction of drug unbound in blood, \(CL_H\) is hepatic blood clearance, and \(E_H\) is the hepatic extraction ratio.

For a simple linear hepatocyte balance, let \(CL_{\mathrm{uptake}}\) describe uptake from blood, \(CL_{\mathrm{return}}\) describe efflux back to blood, and \(CL_{\mathrm{loss}}\) describe irreversible intracellular removal. The loss term can include metabolism and canalicular excretion when both are treated as irreversible hepatic exits. If these clearances are expressed on a compatible basis and intracellular drug is at steady state, the unbound blood concentration \(C_{b,u}\) and intracellular concentration \(C_{\mathrm{cell}}\) satisfy:

CL_{\mathrm{uptake}} C_{b,u} = (CL_{\mathrm{return}}+CL_{\mathrm{loss}})C_{\mathrm{cell}}

The irreversible removal rate is \(CL_{\mathrm{loss}}C_{\mathrm{cell}}\). Substituting the steady-state intracellular concentration gives an effective net clearance:

C_{\mathrm{cell}} = \frac{CL_{\mathrm{uptake}}}{CL_{\mathrm{return}}+CL_{\mathrm{loss}}}C_{b,u}, \qquad CL_{\mathrm{int,net}} = \frac{CL_{\mathrm{uptake}}CL_{\mathrm{loss}}} {CL_{\mathrm{return}}+CL_{\mathrm{loss}}}

This expression is a simple linear representation of transporter-dependent net clearance, not a universal formula for every transporter network. More detailed pathway structures may require a different intracellular balance. For the well-stirred calculation, the essential requirement is that a defensible \(CL_{\mathrm{int,net}}\) is available and is referred to unbound blood concentration.

Deriving the Well-Stirred Equations

The well-stirred assumption treats blood leaving the liver as having the same concentration as the well-mixed hepatic blood compartment. Let \(C_{b,\mathrm{in}}\) and \(C_{b,\mathrm{out}}\) be the total drug concentrations in blood entering and leaving the liver. The unbound concentration at the hepatic outflow is \(f_{u,b}C_{b,\mathrm{out}}\). Under linear intrinsic clearance, hepatic removal is therefore \(f_{u,b}CL_{\mathrm{int,net}}C_{b,\mathrm{out}}\). A steady-state mass balance equates net delivery by blood flow to hepatic removal:

Q_H(C_{b,\mathrm{in}}-C_{b,\mathrm{out}}) = f_{u,b}CL_{\mathrm{int,net}}C_{b,\mathrm{out}}

Rearrange to express the outflow concentration as a fraction of the inflow concentration. The hepatic clearance is the hepatic removal rate divided by the inflow concentration; equivalently, it is \(Q_H\) times the fraction extracted in one passage.

\frac{C_{b,\mathrm{out}}}{C_{b,\mathrm{in}}} = \frac{Q_H}{Q_H+f_{u,b}CL_{\mathrm{int,net}}}

CL_H = \frac{Q_H f_{u,b}CL_{\mathrm{int,net}}} {Q_H+f_{u,b}CL_{\mathrm{int,net}}}, \qquad E_H = \frac{CL_H}{Q_H} = \frac{f_{u,b}CL_{\mathrm{int,net}}} {Q_H+f_{u,b}CL_{\mathrm{int,net}}}

This derivation depends on steady flow and mass balance, a well-mixed liver, constant \(f_{u,b}\), and linear intrinsic removal over the concentration range of interest. It also assumes that the input clearance describes irreversible removal from blood rather than simply uptake into hepatocytes. Uptake followed by return to blood is not, by itself, net hepatic elimination.

Worked Example: Calculating Clearance From Net Intrinsic Clearance

Suppose a hypothetical drug has \(Q_H=90.0\) L/h, \(f_{u,b}=0.0800\), and \(CL_{\mathrm{int,net}}=450\) L/h. Assume these values apply at the concentration of interest and that the well-stirred assumptions hold. Calculate \(CL_H\) and \(E_H\).

First calculate the unbound intrinsic clearance: \(f_{u,b}CL_{\mathrm{int,net}}=0.0800(450)=36.0\) L/h. Then:

CL_H = \frac{(90.0\ \mathrm{L/h})(36.0\ \mathrm{L/h})} {90.0\ \mathrm{L/h}+36.0\ \mathrm{L/h}} = 25.7\ \mathrm{L/h}

The extraction ratio is \(E_H=CL_H/Q_H=25.7/90.0=0.286\), or about 28.6%. Thus, under the model, about 28.6% of the drug entering the liver is removed during a single passage. The result is below \(Q_H\), as the well-stirred equation requires.

How Transporter Processes Enter the Calculation

Transporter effects reach the whole-liver prediction through \(CL_{\mathrm{int,net}}\). Increasing uptake can increase effective delivery into the hepatocyte, but the extent to which this increases irreversible removal depends on what happens after uptake. Greater return efflux can reduce the fraction that is ultimately removed; greater metabolic or biliary loss can increase that fraction. Consequently, neither uptake clearance nor a transporter abundance change should be substituted directly for \(CL_{\mathrm{int,net}}\) without accounting for competing pathways.

Worked Example: Combining Uptake, Efflux, and Intracellular Loss

Consider a hypothetical linear hepatocyte system with \(CL_{\mathrm{uptake}}=120\) L/h, \(CL_{\mathrm{return}}=60\) L/h, and \(CL_{\mathrm{loss}}=200\) L/h. The irreversible loss consists of a metabolic clearance of 180 L/h and a biliary clearance of 20 L/h. Assume all clearances use a compatible basis, intracellular steady state is appropriate, \(Q_H=90.0\) L/h, and \(f_{u,b}=0.100\).

The net intrinsic clearance is:

CL_{\mathrm{int,net}} = \frac{(120)(200)}{60+200} = 92.3\ \mathrm{L/h}

The unbound intrinsic clearance is \(0.100(92.3)=9.23\) L/h. Substitution into the well-stirred equation gives:

CL_H = \frac{(90.0)(9.23)}{90.0+9.23} = 8.37\ \mathrm{L/h}, \qquad E_H=\frac{8.37}{90.0}=0.0930

The predicted extraction ratio is 9.30%. Although uptake clearance is 120 L/h, hepatic clearance is not 120 L/h: the intracellular return and loss pathways first determine net intrinsic clearance, and blood flow and blood binding then determine organ clearance.

A useful algebraic rearrangement shows what can be inferred from an observed hepatic clearance when \(Q_H\) is known. Solving the well-stirred equation for the product \(f_{u,b}CL_{\mathrm{int,net}}\) gives:

f_{u,b}CL_{\mathrm{int,net}} = \frac{Q_HCL_H}{Q_H-CL_H}, \qquad 0\le CL_H<Q_H

Worked Example: Inferring Unbound Intrinsic Clearance

In a hypothetical setting, suppose measured hepatic blood clearance is 30.0 L/h, hepatic blood flow is 100 L/h, and \(f_{u,b}=0.0500\). Assume the measured clearance is adequately described by the well-stirred model. Estimate \(CL_{\mathrm{int,net}}\).

First infer the unbound intrinsic-clearance product:

f_{u,b}CL_{\mathrm{int,net}} = \frac{(100)(30.0)}{100-30.0} = 42.9\ \mathrm{L/h}

Then divide by the blood unbound fraction:

CL_{\mathrm{int,net}} = \frac{42.9}{0.0500} = 857\ \mathrm{L/h}

This inference estimates a net intrinsic clearance, not separate uptake, efflux, or intracellular loss clearances. Many transporter parameter combinations can yield the same net value, so the whole-liver clearance measurement alone cannot identify those individual processes.

Reading the Model and Checking Its Limits

The ratio \(f_{u,b}CL_{\mathrm{int,net}}/Q_H\) compares unbound intrinsic clearance with hepatic blood flow. When that ratio is small, the equation gives \(CL_H\) close to \(f_{u,b}CL_{\mathrm{int,net}}\), so changes in unbound intrinsic clearance can strongly affect clearance. When the ratio is large, \(CL_H\) approaches \(Q_H\); further increases in intrinsic clearance have diminishing impact on the predicted organ clearance. These are consequences of the equation, not evidence that a specific transporter is limiting.

A practical diagnostic is to verify that the calculated \(CL_H\) is nonnegative and less than \(Q_H\), and that \(E_H=CL_H/Q_H\) lies between zero and one. A result outside these bounds points to an arithmetic, unit, parameter-definition, or model-application problem. Also check that \(Q_H\) and \(CL_{\mathrm{int,net}}\) use compatible volume-per-time units, that the unbound fraction is dimensionless and appropriate to blood, and that the input clearance is already net of return to blood.

The model can fail as a quantitative description when its assumptions fail. Examples include concentration-dependent uptake or metabolism, changing binding, substantial hepatic heterogeneity, or a situation in which a single well-mixed concentration does not represent the organ. If intrinsic processes are nonlinear, a single constant clearance may not describe the full concentration range; the effective net clearance must be evaluated at the relevant concentration, or the nonlinear processes must be modeled directly. A mismatch between predicted and observed clearance should therefore prompt checks of both the parameter inputs and the model structure, rather than an automatic adjustment of a transporter parameter.

The well-stirred model is not the only organ model. A parallel-tube model represents drug concentration declining along the liver rather than becoming uniform throughout it; under its standard linear assumptions, it gives \(CL_H=Q_H[1-\exp(-f_{u,b}CL_{\mathrm{int,net}}/Q_H)]\). It can therefore predict a different extraction ratio from the well-stirred model for the same inputs. More detailed compartment or differential-equation models can represent spatial or time-dependent behavior, but require more parameters and supporting data. Model choice should reflect the question and evidence available, not a preference for the more complex equation.

Common pitfall: It is incorrect to set hepatic clearance equal to uptake clearance, or to multiply uptake clearance by blood flow without a mass-balance derivation. Uptake can be followed by return efflux, and even net intrinsic clearance is constrained by flow in the well-stirred model. First calculate or estimate \(CL_{\mathrm{int,net}}\); then use \(Q_H\) and \(f_{u,b}\) to calculate \(CL_H\) and \(E_H\).

Check Your Understanding

Answer each question, then compare your reasoning with the solutions.

If \(f_{u,b}CL_{\mathrm{int,net}}\) is much smaller than \(Q_H\), what does the well-stirred equation predict about \(CL_H\)?
A transporter increases uptake, but the additional intracellular drug is returned to blood rather than irreversibly removed. Is an increase in uptake clearance alone enough to establish an increase in \(CL_{\mathrm{int,net}}\)?
For \(Q_H=80.0\) L/h and \(f_{u,b}CL_{\mathrm{int,net}}=20.0\) L/h, calculate \(CL_H\) and \(E_H\).
Why can observed hepatic clearance and hepatic blood flow identify \(f_{u,b}CL_{\mathrm{int,net}}\), but not necessarily the separate transporter clearances?

Solutions. 1. When \(f_{u,b}CL_{\mathrm{int,net}}\ll Q_H\), the denominator \(Q_H+f_{u,b}CL_{\mathrm{int,net}}\) is close to \(Q_H\), so \(CL_H\) is approximately \(f_{u,b}CL_{\mathrm{int,net}}\). 2. No. Uptake alone does not establish increased net irreversible removal; the fate of intracellular drug, including return efflux and irreversible loss, matters. 3. \(CL_H=(80.0)(20.0)/(80.0+20.0)=16.0\) L/h, and \(E_H=16.0/80.0=0.200\), or 20.0%. 4. Rearranging the well-stirred equation gives the product \(f_{u,b}CL_{\mathrm{int,net}}\). Different combinations of uptake, return, and loss pathways can produce the same product and therefore the same predicted organ clearance.

Embedding Transporter Clearance in the Well-Stirred Liver

What You'll Learn